"I don't believe the FDA would" .... "I think" .... etc etc etc...

First 998 Last

Share
Profile

Follow
col69

15,583 Posts.

5627

16/06/24

13:20

Post #: 74337696
Share

Originally posted by JB1975 ↑

It would dovetail with the new assay tests which FDA have indicated are sufficient for an approval consideration.

This statement goes beyond what even MSB has said.

Leaving aside that like LearningEachDay did once, you are conflating hearsay (MSB or Silviu's statements (it is not even entirely clear what you are believing as I don't think you credit the reporter Cameron England as a particularly reliable source but you haven't said that) with indications from the FDA, not even MSB have stated that the new assay tests specifically were an sufficient for a new approval consideration.

I think you don't believe and are on record as not believing what Cameron England said about January in The Herald Sun and in The Australian. I could be mistaken about you being on record by I don't think so and it doesn't really matter.

I also don't believe you'd believe an FDA official would speak like Cameron England quoted Silviu as saying (which I've already highlighted).

I took (or tried to show LearningEachDay and pledge) and this forum some relevant figures in a patent application (still ungranted - still trying to get a patent on aspects of the two part potency assay matrix) trying to get them to look critically at the still only 11 dots - and you posted back saying you'd looked and including the dots based figure and noting some differences in the statistics but avoiding acknowledging there were still just 11 dots.

The requirement to show that there has been at least one adequate and well controlled study is on MSB as the applicant - MSB has informed the market previously that problems with the potency assay meant that GVHD-001 couldn't be that trial (I'm not quoting but near enough - both bazra and pfeifer1982 have brought the same paragraph to my attention again recently and separately.

As of this point in time MSB have not said since they were going to meeting to talk about potency assay stuff (as I've shown with Silviu speaking in his own voice in a checkable webinar on 7 March 2024 - Hidden Gems) since then MSB has not said it has a validated potency assay. I think it asserted that prior to the second CRL (because it believed or was intending to argue it did - that it was validated on the evidence) but then the FDA rejected it and they couldn't keep repeating they had a validated potency assay as they were still sorting that out with the FDA - well, they still aren't saying they have a validated potency assay anywhere I've seen since 7 March since 27 March - the potency assay could still be the product characterisation issue (I think it is - because I've looked at the patent applications and there still isn't enough there to validate the potency assay).

Expand

"I don't believe the FDA would" .... "I think" .... etc etc etc

Only the FDA and Mesoblast really know what is going on so you can spread all the FUD through your conjecture all you like - you have been proven wrong so many times by many posters before on the MSB forum ... the PDUFA outcome will come soon enough and only then we will all know for sure but whilst we are all speculating - my guess is it will be a 2 month PDUFA date / turnaround

GLTAH

MSB Price at posting: $1.08 Sentiment: Buy Disclosure: Held
14 Upvote

1 Great analysis

Reply

Top Stories

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch

The Rising Tide: How institutional adoption is shaping the future of crypto

SER

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

FXG

What on earth is antimony – and why are ASX traders going crazy for it? + 6 stocks to watch

There are more pages in this discussion • 99 more messages in this thread...

First 998 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 97.0¢		Change 0.015(1.57%)		Mkt cap ! $1.073B

Open	High	Low	Value	Volume
96.0¢	98.5¢	91.5¢	$2.382M	2.515M

Buyers (Bids)

No.	Vol.	Price($)
11	8470	97.0¢

Sellers (Offers)

Price($)	Vol.	No.
97.5¢	62408	21

View Market Depth

No.	Vol.	Price($)
5	4290	0.970
15	57854	0.965
10	57453	0.960
7	130227	0.955
10	75667	0.950

Price($)	Vol.	No.
0.975	62445	18
0.980	89641	10
0.985	181691	19
0.990	176824	11
0.995	50686	4

Last trade - 12.58pm 29/08/2024 (20 minute delay)

MSB (ASX) Chart

"I don't believe the FDA would" .... "I think" .... etc etc etc...

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch

The Rising Tide: How institutional adoption is shaping the future of crypto

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

What on earth is antimony – and why are ASX traders going crazy for it? + 6 stocks to watch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

"I don't believe the FDA would" .... "I think" .... etc etc etc...

Top Stories

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch

The Rising Tide: How institutional adoption is shaping the future of crypto

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

What on earth is antimony – and why are ASX traders going crazy for it? + 6 stocks to watch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News